These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7510927)

  • 21. Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay.
    da Fonseca LM; Brunetti IL; Campa A; Catalani LH; Calado RT; Falcão RP
    Hematol J; 2003; 4(1):26-30. PubMed ID: 12692517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical analysis of monocytic leukemias: usefulness of CD14 and Kruppel-like factor 4, a novel monocyte marker.
    Klco JM; Kulkarni S; Kreisel FH; Nguyen TD; Hassan A; Frater JL
    Am J Clin Pathol; 2011 May; 135(5):720-30. PubMed ID: 21502426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4 predicts nonlymphocytic lineage in acute leukemia. Insights from analysis of 125 cases using two-color flow cytometry.
    Larson RS; McCurley TL
    Am J Clin Pathol; 1995 Aug; 104(2):204-11. PubMed ID: 7543728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of acute myeloid leukemia in dogs using flow cytometry with myeloperoxidase, MAC387, and a canine neutrophil-specific antibody.
    Villiers E; Baines S; Law AM; Mallows V
    Vet Clin Pathol; 2006 Mar; 35(1):55-71. PubMed ID: 16511792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.
    Paietta E; Andersen J; Gallagher R; Bennett J; Yunis J; Cassileth P; Rowe J; Wiernik PH
    Leukemia; 1994 Jul; 8(7):1108-12. PubMed ID: 8035602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosis.
    Aurelius J; Thorén FB; Akhiani AA; Brune M; Palmqvist L; Hansson M; Hellstrand K; Martner A
    Blood; 2012 Jun; 119(24):5832-7. PubMed ID: 22550344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
    Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunophenotypic characterisation of monocytoid differentiation markers in acute non-lymphoblastic leukaemias.
    Liu TC; Tan GB; Wong CL; Han P
    Ann Acad Med Singap; 1991 May; 20(3):353-5. PubMed ID: 1929178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the hemoglobin scavenger receptor (CD163/HbSR) as immunophenotypic marker of monocytic lineage in acute myeloid leukemia.
    Walter RB; Bächli EB; Schaer DJ; Rüegg R; Schoedon G
    Blood; 2003 May; 101(9):3755-6. PubMed ID: 12707228
    [No Abstract]   [Full Text] [Related]  

  • 31. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
    Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discrepancies between morphologic, cytochemical, and immunologic characteristics in acute myeloblastic leukemia.
    del Canizo MC; San Miguel JF; Gonzalez M; Anta JP; Orfao A; Lopez-Borrasca A
    Am J Clin Pathol; 1987 Jul; 88(1):38-42. PubMed ID: 3474879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classifying acute leukemia by immunophenotyping: a combined FAB-immunologic classification of AML.
    Neame PB; Soamboonsrup P; Browman GP; Meyer RM; Benger A; Wilson WE; Walker IR; Saeed N; McBride JA
    Blood; 1986 Dec; 68(6):1355-62. PubMed ID: 3465377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD79 alpha expression in acute myeloid leukemia. High frequency of expression in acute promyelocytic leukemia.
    Arber DA; Jenkins KA; Slovak ML
    Am J Pathol; 1996 Oct; 149(4):1105-10. PubMed ID: 8863659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunophenotype of blast cells in acute myeloid leukemia may be a useful predictive factor for outcome.
    Tucker J; Dorey E; Gregory WM; Simpson AP; Amess JA; Lister TA; Horton MA
    Hematol Oncol; 1990; 8(1):47-58. PubMed ID: 2404842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A; Hrivnáková A; Babusíková O
    Neoplasma; 1993; 40(6):341-5. PubMed ID: 8289964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies differentiating between monocytic and nonmonocytic variants of AML.
    Linch DC; Allen C; Beverley PC; Bynoe AG; Scott CS; Hogg N
    Blood; 1984 Mar; 63(3):566-73. PubMed ID: 6365201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of immune inhibitory receptor ILT3 in acute myeloid leukemia with monocytic differentiation.
    Dobrowolska H; Gill KZ; Serban G; Ivan E; Li Q; Qiao P; Suciu-Foca N; Savage D; Alobeid B; Bhagat G; Colovai AI
    Cytometry B Clin Cytom; 2013; 84(1):21-9. PubMed ID: 23027709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactivity patterns of monoclonal antibodies positive on myelomonocytic leukemia cells as defined by esterase isoenzyme analysis.
    Drexler HG; Menon M; Gaedicke G; Minowada J
    Cancer Immunol Immunother; 1986; 21(3):188-92. PubMed ID: 3457629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.